ACCENDRA HEALTH INC/VA/ (ACH)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter ACCENDRA HEALTH INC/VA/ has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$-1.16
Est. $-0.08 · -1284.2%
Revenue
$613.2M
Est. $628.7M · -2.5%
Net income
$-89.1M
As filed
EPS YoY
+89.7%
vs quarter ended 2025-06-30
Revenue YoY
-10.1%
vs quarter ended 2025-06-30
Next report
Oct 29, 2026
Third-party calendar date, not confirmed by a company filing
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-3.93
2025-09-30 through 2026-06-30
TTM revenue
$2.65B
2025-09-30 through 2026-06-30
Filed quarters
40
On record here
EPS at or above estimate (4Q)
0%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-10 | $-1.16 | $613.2M | +89.7% | -10.1% | $-0.08 | -1284.2% |
| 2026-03-31Q1 FY2026 | 2026-05-11 | $-0.08 | $627.8M | +75.0% | -6.8% | $-0.06 | -33.3% |
| 2025-12-31Q4 FY2025 | 2026-02-20 | $-0.75 | $709.0M | +80.6% | +2.0% | $0.22 | -440.9% |
| 2025-09-30Q3 FY2025 | 2025-10-31 | $-1.94 | $697.3M | -1112.5% | +1.5% | $0.23 | -943.5% |
| 2025-06-30Q2 FY2025 | 2025-08-11 | $-11.30 | $681.9M | -2590.5% | +3.3% | $0.27 | -4285.2% |
| 2025-03-31Q1 FY2025 | 2025-05-08 | $-0.32 | $673.9M | -10.3% | -74.2% | $0.20 | -260.0% |
| 2024-12-31Q4 FY2024 | 2025-02-28 | $-3.86 | $695.0M | -1708.3% | +113.6% | $0.53 | -828.3% |
| 2024-09-30Q3 FY2024 | 2024-11-04 | $-0.16 | $686.8M | -100.0% | -73.5% | $0.40 | -140.0% |
| 2024-06-30Q2 FY2024 | 2024-08-02 | $-0.42 | $660.4M | -13.5% | -74.2% | $0.33 | -227.3% |
| 2024-03-31Q1 FY2024 | 2024-05-03 | $-0.29 | $2.61B | +9.4% | +3.6% | $0.17 | -270.6% |
| 2023-12-31Q4 FY2023 | 2024-02-20 | $0.24 | $-5.13B | +131.6% | -300.9% | $0.68 | -64.7% |
| 2023-09-30Q3 FY2023 | 2023-11-03 | $-0.08 | $2.59B | -150.0% | +3.8% | $0.36 | -122.2% |
| 2023-06-30Q2 FY2023 | 2023-08-04 | $-0.37 | $2.56B | -200.0% | +2.5% | $0.16 | -331.3% |
| 2023-03-31Q1 FY2023 | 2023-05-05 | $-0.32 | $2.52B | -161.5% | +4.8% | $-0.09 | -255.6% |
| 2022-12-31Q4 FY2022 | 2023-02-28 | $-0.76 | $2.55B | -249.0% | +3.4% | $0.39 | -294.9% |
| 2022-09-30Q3 FY2022 | 2022-11-02 | $0.16 | $2.50B | -72.4% | -0.2% | $0.39 | -59.0% |
| 2022-06-30Q2 FY2022 | 2022-08-03 | $0.37 | $2.50B | -57.5% | +0.4% | $0.76 | -51.3% |
| 2022-03-31Q1 FY2022 | 2022-05-04 | $0.52 | $2.41B | -46.9% | +3.5% | $0.77 | -32.5% |
| 2021-12-31Q4 FY2021 | 2022-02-23 | $0.51 | $2.47B | -37.0% | +4.5% | $0.67 | -23.9% |
| 2021-09-30Q3 FY2021 | 2021-11-03 | $0.58 | $2.50B | -23.7% | +14.4% | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-03 | $0.87 | $2.49B | +195.6% | +37.7% | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-05 | $0.98 | $2.33B | +615.8% | +9.6% | — | — |
| 2020-12-31Q4 FY2020 | 2021-02-24 | $0.81 | $2.36B | +224.6% | +7.8% | — | — |
| 2020-09-30Q3 FY2020 | 2020-11-03 | $0.76 | $2.19B | +3700.0% | -4.6% | — | — |
| 2020-06-30Q2 FY2020 | 2020-08-05 | $-0.91 | $1.81B | -435.3% | -23.9% | — | — |
| 2020-03-31Q1 FY2020 | 2020-05-06 | $-0.19 | $2.12B | +17.4% | -9.7% | — | — |
| 2019-12-31Q4 FY2019 | 2020-03-04 | $-0.65 | $2.19B | +85.0% | +3.2% | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-06 | $0.02 | $2.29B | +300.0% | -7.0% | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-07 | $-0.17 | $2.38B | +94.5% | -3.3% | — | — |
| 2019-03-31Q1 FY2019 | 2019-05-07 | $-0.23 | $2.35B | -276.9% | -0.9% | — | — |
| 2018-12-31Q4 FY2018 | 2019-03-06 | $-4.33 | $2.12B | -1239.5% | -11.2% | — | — |
| 2018-09-30Q3 FY2018 | 2018-11-05 | $-0.01 | $2.46B | -105.6% | +5.6% | — | — |
| 2018-06-30Q2 FY2018 | 2018-08-08 | $-3.07 | $2.46B | -1030.3% | +8.5% | — | — |
| 2018-03-31Q1 FY2018 | 2018-05-10 | $0.13 | $2.37B | -58.1% | +1.9% | — | — |
| 2017-12-31Q4 FY2017 | 2018-02-23 | $0.38 | $2.39B | -13.6% | +0.9% | — | — |
| 2017-09-30Q3 FY2017 | 2017-11-02 | $0.18 | $2.33B | -62.5% | -3.4% | — | — |
| 2017-06-30Q2 FY2017 | 2017-08-02 | $0.33 | $2.27B | — | — | — | — |
| 2017-03-31Q1 FY2017 | 2017-05-03 | $0.31 | $2.33B | — | — | — | — |
| 2016-12-31Q4 FY2016 | 2017-02-17 | $0.44 | $2.37B | — | — | — | — |
| 2016-09-30Q3 FY2016 | 2016-11-02 | $0.48 | $2.42B | — | — | — | — |
Need ACH data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.